LeMaitre Vascular Q4 Revenue Up 15.7% and EPS Beats, Shares Jump 16.8%
LeMaitre Vascular posted Q4 revenue of $64.45 million, up 15.7% year-over-year, and EPS of $0.68 versus $0.49 a year ago, driving a 16.8% intraday surge. The company raised first-quarter revenue guidance and set 2026 GAAP EPS at $2.91 midpoint, above analyst consensus.
1. Q4 Financial Highlights
LeMaitre Vascular delivered Q4 sales of $64.45 million, a 15.7% increase year-over-year, and EPS of $0.68 compared with $0.49 in the prior-year quarter. Operating margin expanded to 29.2% from 23.1%, reflecting improved profitability.
2. 2026 Guidance Raised
Management issued first-quarter revenue guidance above consensus and projected 2026 GAAP EPS of $2.91 at the midpoint, exceeding analyst forecasts and signalling confidence in ongoing growth drivers.
3. Market Reaction
Shares surged 16.8% during the morning session to a 52-week high, contributing to a 36.4% year-to-date gain, as investors responded to the stronger-than-expected results and bullish outlook.